Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acetyltryptophan
2. N-acetyl-d-tryptophan
3. N-acetyltryptophan
4. N-acetyltryptophanate Sodium
1. 87-32-1
2. Ac-dl-trp-oh
3. N-acetyltryptophan
4. Dl-acetyltryptophan
5. Acetyltryptophan
6. 2-acetamido-3-(1h-indol-3-yl)propanoic Acid
7. Tryptophan, N-acetyl-
8. Dl-n-acetyltryptophan
9. N-acetyl-dl-tryptophane
10. Dl-tryptophan, N-acetyl-
11. Nsc49124
12. Mfcd00005644
13. Nsc 49124
14. Tryptophan, N-acetyl-, Dl-
15. Chebi:70976
16. 4460nbv53f
17. N-acetyl-trp-oh
18. Nsc-49124
19. N-acetyl Tryptophan
20. N-acetyltryptophan #
21. N-acetyl-dl-tryptophen
22. Nalpha-acetyl-dl-tryptophan
23. N-alpha-acetyl-dl-tryptophan
24. Unii-4460nbv53f
25. Mfcd00065976
26. Nsc-90726
27. N-acetyltryptophane
28. Einecs 201-739-3
29. Acetyl-dl-tryptophan
30. N-a-acetyltryptophan
31. N-acetyl Dl-tryptophan
32. N-acetyl-d,l-tryptophan
33. D,l-alpha-acetylamino-3-indolepropionic Acid
34. Cambridge Id 5117020
35. N-
36. A-acetyl-dl-tryptophan
37. Nciopen2_005595
38. Oprea1_817403
39. Schembl57140
40. Acetyltryptophan, Dl-
41. Cbdive_014228
42. 2-(acetylamino)-3-(1h-indol-3-yl)propanoic Acid
43. Mls000686793
44. Chembl1905494
45. Acon1_001308
46. Bdbm91686
47. Dzthigrzjzprdv-uhfffaoysa-
48. Acetyltryptophan [who-dd]
49. Dtxsid40861672
50. Hms2271l03
51. Hms3372o11
52. Acetyltryptophan, Dl- [ii]
53. Act05774
54. Nsc90726
55. Bbl000688
56. Ccg-41706
57. Stk367673
58. Akos000120599
59. Akos016040255
60. Am82276
61. Cs-w012698
62. Hy-w011982
63. N-acetyltryptophan [ep Monograph]
64. Ac-19242
65. Ac-27041
66. Nci60_004180
67. Smr000339886
68. Sy036184
69. Sy036799
70. Vs-00668
71. Db-041633
72. Db-045994
73. Db-056991
74. A0120
75. Dl-.alpha.-acetamidoindole-3-propionic Acid
76. Ft-0629814
77. Ft-0633493
78. Ft-0634178
79. Dl-.alpha.-acetylamino-3-indolepropionic Acid
80. 2-acetamido-3-(1h-indol-3-yl)-propionic Acid
81. A-1810
82. A13889
83. D,l-.alpha.-acetylamino-3-indolepropionic Acid
84. 2-acetylamino-3-(1h-indol-3-yl)propionic Acid
85. Ab00637124-07
86. 005a644
87. A804795
88. Sr-01000597217
89. J-300264
90. Sr-01000597217-1
91. Sr-01000597217-2
92. Brd-a18626878-001-01-6
93. Q27139225
94. Z85881713
95. 3ad26bd1-c587-4301-9682-da13678ce54f
96. Ncgc00180645-03!2-acetamido-3-(1h-indol-3-yl)propanoic Acid
97. N-acetyl-dl-tryptophan, Pharmagrade, Manufactured Under Appropriate Gmp Controls For Pharma Or Biopharmaceutical Production.
98. N-acetyl-dl-tryptophan, Pharmagrade, Manufactured Under Appropriate Gmp Controls For Pharma Or Biopharmaceutical Production., Ep
Molecular Weight | 246.26 g/mol |
---|---|
Molecular Formula | C13H14N2O3 |
XLogP3 | 1.1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 246.10044231 g/mol |
Monoisotopic Mass | 246.10044231 g/mol |
Topological Polar Surface Area | 82.2 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 332 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Protease Inhibitors
Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A N-Acetyl DL-Tryptophan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Acetyl DL-Tryptophan, including repackagers and relabelers. The FDA regulates N-Acetyl DL-Tryptophan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Acetyl DL-Tryptophan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N-Acetyl DL-Tryptophan supplier is an individual or a company that provides N-Acetyl DL-Tryptophan active pharmaceutical ingredient (API) or N-Acetyl DL-Tryptophan finished formulations upon request. The N-Acetyl DL-Tryptophan suppliers may include N-Acetyl DL-Tryptophan API manufacturers, exporters, distributors and traders.
click here to find a list of N-Acetyl DL-Tryptophan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A N-Acetyl DL-Tryptophan DMF (Drug Master File) is a document detailing the whole manufacturing process of N-Acetyl DL-Tryptophan active pharmaceutical ingredient (API) in detail. Different forms of N-Acetyl DL-Tryptophan DMFs exist exist since differing nations have different regulations, such as N-Acetyl DL-Tryptophan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A N-Acetyl DL-Tryptophan DMF submitted to regulatory agencies in the US is known as a USDMF. N-Acetyl DL-Tryptophan USDMF includes data on N-Acetyl DL-Tryptophan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N-Acetyl DL-Tryptophan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of N-Acetyl DL-Tryptophan suppliers with USDMF on PharmaCompass.
A N-Acetyl DL-Tryptophan CEP of the European Pharmacopoeia monograph is often referred to as a N-Acetyl DL-Tryptophan Certificate of Suitability (COS). The purpose of a N-Acetyl DL-Tryptophan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of N-Acetyl DL-Tryptophan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of N-Acetyl DL-Tryptophan to their clients by showing that a N-Acetyl DL-Tryptophan CEP has been issued for it. The manufacturer submits a N-Acetyl DL-Tryptophan CEP (COS) as part of the market authorization procedure, and it takes on the role of a N-Acetyl DL-Tryptophan CEP holder for the record. Additionally, the data presented in the N-Acetyl DL-Tryptophan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the N-Acetyl DL-Tryptophan DMF.
A N-Acetyl DL-Tryptophan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. N-Acetyl DL-Tryptophan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of N-Acetyl DL-Tryptophan suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing N-Acetyl DL-Tryptophan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for N-Acetyl DL-Tryptophan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture N-Acetyl DL-Tryptophan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain N-Acetyl DL-Tryptophan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a N-Acetyl DL-Tryptophan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of N-Acetyl DL-Tryptophan suppliers with NDC on PharmaCompass.
N-Acetyl DL-Tryptophan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Acetyl DL-Tryptophan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-Acetyl DL-Tryptophan GMP manufacturer or N-Acetyl DL-Tryptophan GMP API supplier for your needs.
A N-Acetyl DL-Tryptophan CoA (Certificate of Analysis) is a formal document that attests to N-Acetyl DL-Tryptophan's compliance with N-Acetyl DL-Tryptophan specifications and serves as a tool for batch-level quality control.
N-Acetyl DL-Tryptophan CoA mostly includes findings from lab analyses of a specific batch. For each N-Acetyl DL-Tryptophan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Acetyl DL-Tryptophan may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Acetyl DL-Tryptophan EP), N-Acetyl DL-Tryptophan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Acetyl DL-Tryptophan USP).
LOOKING FOR A SUPPLIER?